Ahn-Gook Pharmaceutical Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was KRW 0.00049 million compared to KRW 0.00012 million a year ago. Net income was KRW 3,876.99 million compared to KRW 1,410.85 million a year ago. Basic earnings per share from continuing operations was KRW 341 compared to KRW 123 a year ago. Diluted earnings per share from continuing operations was KRW 341 compared to KRW 123 a year ago. Basic earnings per share was KRW 341 compared to KRW 123 a year ago.
For the nine months, sales was KRW 0.00039 million compared to negative sales of KRW 0.00018 million a year ago. Net income was KRW 6,330.45 million compared to KRW 798.4 million a year ago. Basic earnings per share from continuing operations was KRW 556 compared to KRW 70 a year ago. Diluted earnings per share from continuing operations was KRW 556 compared to KRW 70 a year ago. Basic earnings per share was KRW 556 compared to KRW 70 a year ago.